by Chilmark Team | December 18, 2020
Looking to the Future – 2021 Predictions
Unlike past years when we have written a post evaluating how well our predictions for that year held up, let’s […]
Tag Archive: FDA
by Chilmark Team | December 18, 2020
Unlike past years when we have written a post evaluating how well our predictions for that year held up, let’s […]
by Jody Ranck | October 15, 2020
While COVID-19 has been dominating the healthcare headlines so far in 2020 there have been a number of recent policy and regulatory decisions bearing on the AI/ML market in healthcare.
by Alex Lennox-Miller | January 30, 2020
Roughly two years after we reviewed the first FDA guidance on Clinical Decision Support (CDS), FDA issued new draft guidance. […]
by Chilmark Team | December 10, 2018
The Meaningful Use gravy train finally came to an end in 2018. As the strongest EHR vendors struggle to define […]
by Chilmark Team | November 29, 2018
As is our custom here, we like to look back on our predictions for the closing year and see just […]
by Brian Edwards | December 19, 2017
Key Takeaways: The FDA has released long-anticipated draft guidance on how they intend to regulate clinical decision support products. For […]
by Naveen Rao | July 27, 2015
Progress? Healthcare organizations (HCOs) are acknowledging the need for next generation tools to realize the promise of newer models of […]
by Naveen Rao | March 28, 2015
A Worthy Read This month’s Domain Monitor is a little bit different. We recently read through Dr. Eric Topol’s latest […]
Chilmark Team · 1 month ago
Chilmark Team · 2 months ago
John Moore III · 2 weeks ago